Bayer Aktiengesellschaft (BAYRY) Q3 2026 Earnings Call November 3, 2026 4:00 AM EST
Company Participants
Michael Preuss – Head of Communications, Government Relations and Corporate Brand
William Anderson – Chairman of the Management Board & CEO
Judith Hartmann – CFO & Member of Management Board
Conference Call Participants
Sonja Wind
Kevin Grogan
Patrick Thomas
Antje Honing
Patricia Weiss – Thomson Reuters Corporation
Ayisha Sharma – Endpoints News Media Company, LLC
Jonas Jansen
Andrew Noel
Presentation
Michael Preuss
Head of Communications, Government Relations and Corporate Brand
Good morning, and welcome to our media update for the third quarter 2026. Many thanks for joining. For today’s presentation, Bill will provide an update on our year-to-date business performance and strategic priorities, and then Judith will walk you through the key drivers of our results and the outlook. And after that, we’ll have time for your questions.
Now before starting, I would like to briefly draw your attention to the cautionary language included in our safe harbor statement. And with that, over to you, Bill.
William Anderson
Chairman of the Management Board & CEO
Thanks, Michael. Hi, everyone. We posted our results for the third quarter earlier today. And 9 months into the year, we’re on track to deliver our commitments with a strong operational performance, and we’re even upgrading our outlook in several areas. So sales grew 3% organically or currency and portfolio adjusted, which we’ll refer to throughout today’s call. Core EPS is at EUR 3.97, in line with our guidance despite some effects on the corporate lines. As expected, free cash flow is at negative EUR 3 billion due to known litigation-related payments. On the whole, our business has demonstrated operational resilience and underlying potential. Crop Science and Consumer Health are performing in line with targets while navigating market pressures. And our Pharma business, led by Nubeqa and Kerendia demonstrates its growth momentum.